MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Boston Scientific Corporation Book Value 2011-2026 | BSX
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Boston Scientific Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.7 B | 39.4 B | 35.1 B | 32.5 B | 32.2 B | 30.8 B | 13.9 B | 8.73 B | 7.01 B | 6.73 B | 6.32 B | 6.46 B | 6.54 B | 6.87 B | 11.4 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 43.7 B | 6.32 B | 19.2 B |
Quarterly Book Value Boston Scientific Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42.7 B | 41.6 B | 40.1 B | 38.1 B | 37.1 B | 36.7 B | 34 B | 33.6 B | 32.9 B | 32.5 B | 31.9 B | - | 32.3 B | 32.2 B | 31.9 B | 31.2 B | 30.9 B | 30.8 B | 30.8 B | 30.8 B | 30.8 B | 30.6 B | 30.6 B | 30.6 B | 30.6 B | 21 B | 21 B | 21 B | 21 B | 19 B | 19 B | 19 B | 19 B | 18.1 B | 18.1 B | 18.1 B | 18.1 B | 18.1 B | 18.1 B | 18.1 B | 18.1 B | 17 B | 17 B | 17 B | 17 B | 16.6 B | 16.6 B | 16.6 B | 16.6 B | 17.2 B | 17.2 B | 17.2 B | 17.2 B | 21.3 B | 21.3 B | 21.3 B | 21.3 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 42.7 B | 16.6 B | 25 B |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
5.12 M | $ 2.22 | - | $ 3.47 M |  USA |
 |
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.53 B | $ 10.36 | -0.86 % | $ 1.4 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
196 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 12.95 | -0.77 % | $ 1.94 B | USA |
 |
Lianluo Smart Limited
LLIT
|
272 M | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
217 M | $ 8.36 | - | $ 600 M |  Israel |
 |
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
169 M | $ 4.17 | -2.11 % | $ 883 M | USA |
 |
ClearPoint Neuro
CLPT
|
28 M | $ 10.09 | -9.59 % | $ 286 M | USA |
 |
BIOLASE
BIOL
|
1.96 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
11.1 M | $ 0.68 | 0.71 % | $ 37 M | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.9 M | $ 4.0 | -1.23 % | $ 149 M |  France |
 |
CONMED Corporation
CNMD
|
1.03 B | $ 36.89 | -0.78 % | $ 1.14 B | USA |
 |
InMode Ltd.
INMD
|
683 M | $ 13.65 | - | $ 882 M | Israel |
 |
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | USA |
 |
Establishment Labs Holdings
ESTA
|
23.5 M | $ 64.4 | -0.95 % | $ 1.91 B |  Costa-rica |
 |
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
146 M | $ 18.43 | -0.11 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
550 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
2.81 M | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
86.7 B | $ 109.42 | -1.2 % | $ 191 B | USA |
 |
Delcath Systems
DCTH
|
111 M | $ 9.58 | -1.64 % | $ 343 M | USA |
 |
Bio-Rad Laboratories
BIO
|
6.57 B | $ 266.27 | -1.15 % | $ 7.51 B | USA |
 |
IRIDEX Corporation
IRIX
|
9.52 M | $ 1.33 | - | $ 21.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
347 M | $ 17.02 | -1.07 % | $ 399 M | USA |
 |
Helius Medical Technologies
HSDT
|
2.35 M | $ 2.11 | -2.88 % | $ 1.28 M | USA |
 |
AxoGen
AXGN
|
129 M | $ 32.52 | -0.7 % | $ 1.5 B | USA |
 |
Align Technology
ALGN
|
3.85 B | $ 174.5 | -0.92 % | $ 13.1 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.55 B | $ 8.95 | -1.65 % | $ 689 M | USA |
 |
Bruker Corporation
BRKR
|
1.82 B | $ 33.37 | -1.1 % | $ 4.97 K | USA |
 |
BioSig Technologies
BSGM
|
-1.42 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
14.8 M | $ 3.8 | 1.6 % | $ 156 M | USA |
 |
Second Sight Medical Products
EYES
|
17.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
81.2 M | $ 0.38 | -1.84 % | $ 39.1 M | USA |
 |
IRadimed Corporation
IRMD
|
94.6 M | $ 102.06 | -0.72 % | $ 1.3 B | USA |